Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors-Reference-Cited by-同舟云学术

Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors

Published:2018-01 Issue: Volume:143 Page:2005-2014
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cincinelli Raffaella,Musso Loana,Artali Roberto,Guglielmi Mario,Bianchino Erminia,Cardile Francesco,Colelli Fabiana,Pisano Claudio,Dallavalle Sabrina^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference38 articles.

1. Selective Histone Deacetylase Inhibitors with Anticancer Activity

2. Macrocyclic inhibitors of zinc-dependent histone deacetylases (HDACs);Ganesan,2015

3. Phenolic constituents of

4. Brominated tyrosine metabolites from an unidentified sponge

5. Two bromotyrosine-cysteine derived metabolites from a sponge

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review;Cancers;2024-02-06

2. Anticancer activity of natural compounds from marine animals;Natural Products as Anticancer Agents;2024

3. The recent developments of camptothecin and its derivatives as potential anti-tumor agents;European Journal of Medicinal Chemistry;2023-11

4. Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework;Bioorganic & Medicinal Chemistry Letters;2023-05

5. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors;Annals of Medicine;2023-04-24